Arnica tincture for treating cutaneous leishmaniasis
Part of Infections, Skin clinical trials.
This trial tests whether arnica tincture (a plant extract) can treat cutaneous leishmaniasis, an infection causing skin ulcers. It compares arnica to a standard injected treatment and looks at how well each works and how safe they are.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 12 years old and have been diagnosed with cutaneous leishmaniasis (a skin infection confirmed by lab tests)
- You have up to 9 skin sores (ulcers, nodules, or plaques) that together are no larger than about 1.9 inches (2.5 cm) across
- You have not had treatment for leishmaniasis in the last 8 weeks (56 days)
- You are not pregnant, breastfeeding, or planning to become pregnant during the study (if female of childbearing age, you must use birth control)
- You have no serious heart, kidney, liver, nerve, or immune system problems, and no allergies to arnica or pentavalent antimonials
- You can attend follow-up visits for up to 3 months and follow the study rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests medicines added to standard treatment to improve healing of complicated skin sores (leishmaniasis) by balancing the bacteria on the skin. You may qualify if you have sores that need whole-body treatment and you are willing to stay in the hospital for 4 weeks.
This study tests how your immune system responds to parts of a potential vaccine for leishmaniasis. Doctors will take small blood or skin samples to see if your body's cells react to these vaccine pieces, which could help design a better vaccine in the future.
This study watches how leishmaniasis affects children over time. It helps doctors learn more about the disease in kids so they can improve care.
This trial compares two approaches for treating skin sores caused by Leishmania: standard injections alone versus injections plus a laser treatment. It aims to see if adding laser therapy improves healing.
This study tests different drugs to find which works best for cutaneous leishmaniasis (a skin infection from a parasite). It may help people with many or large sores, or sores in sensitive areas like near the eyes or nose.
This study tests if using heat therapy (thermotherapy) in local clinics is a good way to treat skin sores caused by leishmaniasis. It may be an option for people with a few small sores not on the face or near sensitive areas.
Hear when a new Leishmaniasis, Cutaneous trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.